Medical Oncologist & Hemato-Oncologist
Dr. Anup Toshniwal
MBBS, MD (Medicine), DM (Medical Oncology – Tata Memorial Hospital, Mumbai)
Dr. Anup Toshniwal is a medical oncologist trained at Tata Memorial Hospital, Mumbai. He treats all solid cancers and blood cancers with chemotherapy, targeted therapy and immunotherapy, and performs procedures such as bone marrow biopsy and intrathecal chemotherapy.
Areas of expertise
- Chemotherapy, targeted therapy and immunotherapy for all solid cancers
- Breast, lung, gastrointestinal, gall bladder, head & neck, gynaecological and urological cancers
- Lymphoma, leukaemia and myeloma (hemato-oncology)
- Bone marrow aspiration & biopsy, lumbar puncture, intrathecal chemotherapy
- Second opinions and tumour board review
Education
- MBBS – Government Medical College, Chhatrapati Sambhajinagar
- MD (General Medicine) – Kasturba Medical College, Mangalore
- DM (Medical Oncology) – Tata Memorial Hospital, Mumbai
- ESMO certification – European Society for Medical Oncology
- ACORD Fellow – Clinical Oncology Research Development workshop, Australia
Positions
- Senior Consultant Medical Oncologist – Medicover Hospital, Chhatrapati Sambhajinagar
- Associate Professor – Government Cancer Hospital, Chhatrapati Sambhajinagar
- Former Assistant Professor – Tata Memorial Hospital, Mumbai
- Teaching faculty for DM (Medical Oncology) and MD (Medicine) courses
- Director – Shree We Care Clinic
Publications
- Downstaging with neoadjuvant chemotherapy in locally advanced gall bladder cancer improves outcomes – Annals of Oncology
- Toxicity and early outcomes of regorafenib in multiply pre-treated metastatic colorectal adenocarcinoma – experience from a tertiary cancer centre in India
- Modified 5-FU / leucovorin / irinotecan as a feasible and efficacious second-line regimen in advanced gastric cancer
- Quality-of-life (Q-TWiST) analysis of a randomised trial comparing cabazitaxel versus docetaxel in recurrent head and neck cancer
- Efficacy of artesunate for cytomegalovirus reactivation in allogeneic stem cell transplant recipients
- Use of leflunomide for cytomegalovirus infection in allogeneic stem cell transplant recipients
- NUT midline carcinoma (case report)
- Bleomycin-induced skin rash (case report)